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Objective: To present a retrospective analysis of patient- and sonication-related
parameters of a group of patients treated with a transcranial magnetic resonance imaging
(MRI)-guided focused ultrasound (tcMRgFUS) system integrated with a 1.5-T MRI unit.
Methods: The data obtained from 59 patients, who underwent the tcMRgFUS
procedure from January 2015 to April 2019, were retrospectively reviewed for this study.
The following data, among others, were mainly collected: skull density ratio (SDR), skull
area (SA), number of available transducer elements (Tx), and estimated focal power at
target (FP). For each of the four different treatment stages, we calculated the number of
sonication processes (Sn), user-defined sonication power (Sp), effective measured power
(Smp), sonication duration (Sd), user-defined energy (E), effective measured energy (Em),
maximum temperature (Tmax), and MR thermometry plane orientation. Furthermore, the
time delay between each sonication (St) and the total treatment time (Tt) were recorded.
Results: Fifty-two patients (40 males and 12 females; age 64.51 ± SD 11.90 years;
range 26–86 years), who underwent unilateral Vim thalamotomy (left= 50, 96.15%; right
= 2, 3.85%) for medication-refractory essential tremor (n= 39; 78%) or Parkinson tremor
(n = 13; 22%) were considered. A total of 1,068 (95.10%) sonication processes were
included in our final analysis (average Sn per treatment: 20.65 ± 6.18; range 13–41).
The energy released onto the planned target was found to decrease with the SDR for
all temperature ranges. A positive correlation was observed between the slope of Tmax
vs. Em plot and the SDR (R
2 = 0.765; p < 0.001). In addition, the Tmax was positively
correlated with SDR (R2 = 0.398; p < 0.005). On the contrary, no significant correlation
was found between SDR and SA or Tx. An analysis of the MR thermometry scanning
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plane indicated that, at our site, the axial and the coronal planes were used (on average)
10.4 (SD ± 3.8) and 7.7 (SD ± 3.0) times, respectively, whereas the sagittal plane was
used only 2.5 (SD ± 3.0) times per treatment.
Conclusion: Our results confirm the factors that significantly influence the course of a
tcMRgFUS procedure even when a 1.5-T MRI scanner is used for procedure guidance.
The experience we gained in this study indicates that the SDR remains one of the
most significant technical parameters to be considered in a tcMRgFUS procedure. The
possibility of prospectively setting the sonication energy according to the presented
curves of energy delivery as a function of SDR for each treatment stage could provide a
further understanding and a greater awareness of this emerging technology.
Keywords: high-intensity focused ultrasound ablation, interventional magnetic resonance imaging, stereotaxic
techniques, essential tremor, Parkinson’s disease
INTRODUCTION
Magnetic resonance imaging-guided focused ultrasound
(MRgFUS) is a non-invasive thermal ablation method that
involves high-intensity FUS energy and MRI for anatomical
imaging and real-time thermal mapping [1]. Thanks to novel
technology, it is now possible to create a sharp focal point in
the planned target through an intact skull for the treatment
of neurological disorders [transcranial MRgFUS (tcMRgFUS)]
[2]. As a result, a major feat has been achieved in the field
of therapeutic brain lesioning, which was previously partially
abandoned over the years and increasingly replaced by deep
brain stimulation (DBS) since its introduction in the late 1980s
[3]. Radio-frequency stereotactic ablation is invasive (skin and
skull incisions) and involves a few risks (infections, hemorrhage,
imprecise targeting) [4]. Stereotactic radiosurgery, although
non-invasive, utilizes ionizing radiations; furthermore, targeting
is performed only using atlas coordinates, and the physicians
cannot anticipate the clinical results because the radiobiological
effects occur delayed and are not always predictable [4]. Although
DBS is invasive and involves procedure-related risks, possible
hardware malfunction, and requires battery replacement that
may discourage patients [3, 5], it has been widely employed
in the past few years because it introduced the prospect of
neuromodulation. On the contrary, the tcMRgFUS method
does not use ionizing radiation and is non-invasive; in addition,
patient feedback allows the physician to optimize the target
before a permanent lesion is made because its clinical effects can
be evaluated immediately. Clinical results of tcMRgFUS systems
integrated with 3-T MRI units have already been reported for
patients with essential tremor (ET) [6], Parkinson’s disease (PD)
[7–9], neuropathic pain [10], and psychiatric disorders [11];
these results have indicated the possibility of a wide range of
experimental applications [12–14]. In recent years, because of
the use of a dedicated surface coil, which allows considerable
gain in terms of signal-to-noise ratio [15], the tcMRgFUS
procedure has been performed with MRI units operating at 1.5 T
[16]. Although numerous studies have been conducted on this
subject, most studies are focused only on the clinical aspects,
and some technical limits thus remain to be investigated. In
2015, Chang et al. [17] studied the correlation between the skull-
related factors and the maximal area temperature using samples
obtained from 25 patients who were treated with a tcMRgFUS
system integrated with a 3-T unit. More recently, D’Souza et al.
[18] investigated the influence of skull bone characteristics on
the efficacy and safety of FUS procedure; furthermore, Boutet
et al. [19] studied the significance of skull bone characteristics
in selecting candidates for the procedure. Furthermore, Jung
et al. [20] investigated the technical limitations of the acoustic
properties of skull (five non-embalmed cadaver skulls and 46
patients who underwent the tcMRgFUS procedure) to identify
the skull density ratio (SDR), skull volume, and incidence angle
of acoustic rays against the skull surface as the important factors
to establish a successful procedure.
Accordingly, we present a retrospective analysis on the
dependence of treatment-related parameters on patient-related
features for a series of patients who were treated with a
tcMRgFUS system integrated with a 1.5-T MRI unit.
MATERIALS AND METHODS
The institutional review board approved this study, and all
of the patients signed an informed consent for this study in
accordance with the Declaration of Helsinki. The data obtained
from 59 patients who underwent the tcMRgFUS procedure at
our university hospital from January 2015 to April 2019 were
retrospectively reviewed for this study.
The ExAblate 4000 (InSightec Ltd, Haifa, Israel) integrated
with a Signa HDxt 1.5-T MRI unit (GE Medical Systems,
Milwaukee, Wisconsin, USA) is the tcMRgFUS system available
in our facility.
Only the patients who underwent the tcMRgFUS procedure
with a clearly visible lesion in intraoperative imaging were
selected for this study. Intraoperative imaging was realized using
a dedicated two-channel coil embedded into an elastic membrane
that is placed on the patient’s head and fixed to the transducer to
achieve a watertight seal [15]. Furthermore, we used an axial 2-
D T2-weighted (T2w) fast recalled fast spin-echo (FRFSE) pulse
sequence as the MRI sequence to identify thalamic lesions. This
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MRI sequence has been scanned based on the requirements of
the treating physician, among high-energy sonications, and for
final lesion assessment at the end of the procedure just before
water drainage from the helmet and discharging the patient from
the treating table. The scan parameters were as follows: slice
thickness 2mm; no gap; TR 4,461ms; TE 103ms; ETL 19; FOV
22 cm2 × 22 cm2; matrix 384 × 288; NEX 2; number of slices 19
(AC-PC alignment, basal ganglia region coverage).
For each patient, the SDR and the skull area (SA) exposed to
the transducer were calculated using the ExAblate workstation,
from the screening head CT scan obtained approximately 3
months prior to the treatment using a 16-row multidetector
CT scanner (BrightSpeed, GE Medical Systems, Milwaukee,
Wisconsin, USA). The CT scan parameters were as follows: tube
voltage 120 kV, tube current 220mA, pure axial plane (0◦ gantry
tilting), sequential acquisition, slice thickness 1.25mm, and bone
kernel (GE bone plus, WL 600/WW 2500).
The ExAblate workstation calculates the SDR score by
dividing the skull CT dataset into small samples and calculating
the average of the ratio between the trabecular and the cortex
bone CT values (in Hounsfield units) for all voxels of the
samples [17]. Therefore, a homogeneously compact skull (i.e.,
trabecular layer is negligible) has an SDR score of 1, whereas
a skull characterized by a highly represented trabecular layer
has a smaller SDR score (closer to 0). Knowledge of this
score is mandatory to apply a phase correction algorithm
[2] that enables the tcMRgFUS system to achieve a coherent
summation of sufficient energy delivery to the planned target via
a compensation of the different speeds of the US beam through
bone to that of the soft tissues, along with the variability in skull
thickness and incidence angle of acoustic rays against the skull
surface [17, 21].
The SA was calculated during the treatment simulations (SAs)
(by accordingly planning the target and the transducer location)
and the actual treatment (SAt) using the ExAblate workstation.
Each treatment was titrated by sonication (in steps of
small energy increments) to first verify the alignment of the
thermal spot in all three axes and then perform treatment
retargeting based on real-time feedback from patients prior to
actual lesioning. Furthermore, the temperatures were calculated
using the ExAblate software by real-time MR thermometry
based on proton resonance frequency (PRF) shift of water
molecules by considering a baseline temperature of 37◦C
(MR thermometry sequence parameters: gradient echo pulse
sequence, TR 26.172ms, TE 12.996ms, FA 30, slice thickness
3mm, FOV 28 cm2 × 28 cm2, matrix 256 × 128, bandwidth
43.4375 Hz/pixel, temporal resolution 3.5 s). Four different
typical consecutive treatment stages, each characterized by a
maximum temperature (Tmax) limit at the target area, were
considered: stage I: thermal spot alignment (Tmax ≤ 45
◦C);
stage II: real-time clinical evaluation prior to actual lesioning
(45◦C < Tmax ≤ 50
◦C); stage III: permanent lesioning with low
power (50◦C < Tmax ≤ 55
◦C); stage IV: lesion consolidation
with high power (Tmax > 55
◦C). For each treatment, the
following treatment-related parameters were collected: number
of sonication processes (Sn), user-defined sonication power
(Sp), effective measured power (Smp), sonication duration
(Sd), user-defined energy (E), effective measured energy (Em),
maximum temperature (Tmax), and MR thermometry plane
orientation (Ax, axial; Cor, coronal; Sag, sagittal).
All of the sonication-related parameters were calculated for
the abovementioned treatment stages. If no significant amount of
energy was achieved (Smp ≤ 50% of Sp and Em ≤ 50% of E), the
sonication was defined as inconsistent. All sonication processes,
aborted by the patient, by the treating (or the monitoring)
physician before a significant amount of energy was released (Smp
≤ 50% of Sp and Em ≤ 50% of E), or because of any technical
failure and device malfunction, were considered inconsistent and
were thus excluded from the statistical analysis.
All patient-related parameters were calculated during the
simulations and the actual treatments after marking as no
pass regions sensible structures (i.e., frontal sinuses, intracranial
calcifications, skin defects as scars or nevi) and elastic membrane
folding (for treatment sessions only). Furthermore, the following
parameters were considered: number of transducer elements (Txs
for simulations and Txt for actual treatment) and estimated
focal power at the target (FPs for simulations and FPt for actual
treatment). In addition, the time delay between each sonication
(St) and the duration of the entire procedure (treatment time: Tt)
(considering the time elapsed from the first to the last sonication)
were recorded. Patients with SDR ≤ 0.3, and/or SA < 250
cm2, and/or Txs elements < 700 at our university hospital were
excluded from this study after performing treatment simulations
and did not undergo the tcMRgFUS procedure.
The correlations between the abovementioned parameters
were calculated, along with the corresponding p-values using the
Pearson formula.
The programs, which were developed on an ad hoc basis, used
in this study were written in Python language using the package
for Scientific computing (SciPy) [22] within the framework of
SageMath [23]. This software automatically reads the output files
produced by the ExAblate workstation, evaluates the average
values for the various parameters considered, estimates the
correlations between these parameters, and generates output
plots. The main advantage of this software is that, once
implemented, it could automatically analyze an arbitrary number
of datasets of patients from different sites (if available).
RESULTS
Of the total number of 59 patients, only the data of 52
tcMRgFUS procedures were considered in this study because two
procedures were aborted, four failed, and the data of a successful
bilateral central lateral thalamotomy procedure were excluded
(see Table S1). No patient was excluded because of low SDR
and/or SA and/or Txs elements. The demographic data (sex, age,
and disease) and patient- (thalamotomy side, SDR, SA, Tx, and
FP) and treatment-related (Sn and Tt) parameters are provided
in Table 1.
A total of 1,123 sonication processes were performed
in our retrospective analysis. Furthermore, 55 sonication
processes (4.90%) were considered inconsistent, and the data
of the remaining 1,068 sonication processes (95.10%) were
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TABLE 1 | Summary of patient demographics and treatment data included in the
final analysis.
Characteristics Number
Patients 52
Gender
Males 40 (76.92%)
Females 12 (23.08%)
Age
Mean ± SD 64.51 ± 11.90
Range 26–86
Tremor etiology
Essential tremor 39 (78%)
Parkinson tremor* 13 (22%)
Thalamotomy side
Left Vim 50 (96.15%)
Right Vim 2 (3.85%)
Skull density ratio—SDR
Mean ± SD 0.51 ± 0.10
Range 0.34–0.74
Skull Area—SAs (SAt)
Mean ± SD 359 (344) ± 25.3 (27.5)
Range 289–406 (293–410)
Number of transducer elements—Txs (Txt)
Mean ± SD 959 (927.5) ± 24.6 (50.61)
Range 880–998 (799–1,000)
Focal Power—FPs (FPt)
Mean ± SD 12 (13.3) ± 7.73 (12.8)
Range 2–51(4-68)
Number of sonication processes—
Sn (stage I—alignment)
Mean ± SD 3.25 ± 2.06
Range 3–9
Number of sonication processes—
Sn (stage II—verification)
Mean ± SD 6.60 ± 3.60
Range 1–18
Number of sonication processes—
Sn (stage III—treat low)
Mean ± SD 6.48 ± 3.52
Range 1–17
Number of sonication processes—
Sn (stage IV—treat high)
Mean ± SD 4.21 ± 3.34
Range 0–14
Treatment time (Tt)
Mean ± SD 2h 17m ± 45 m
Range 1 h 12 m−3 h 58 m
Age is expressed in years, SA in square centimeters, Tx as the number of available
elements, and FP in watts. *A patient with both tremor and Parkinsonism, who underwent
the tcMRgFUS Vim ablation procedure in 6 months after the first treatment, has been
included in this group [24].
included in the final analysis (with an average sonication
number per treatment of 20.65 ± 6.18; range 13–41). The
number of sonication processes per treatment stage averaged
over patients (with related standard deviation and range)
is provided in Table 1. Furthermore, the summary of the
sonication parameters for each treatment stage is reported
in Table 2.
Moreover, the dependence of the energy released onto the
planned target as a function of the SDR was considered.
Specifically, the effective Em (calculated by the ExAblate
workstation) averaged over patients and sonication processes
was calculated for the four treatment stages. The total SDR
range was subdivided, as shown in Figure 1. For all temperature
ranges, Em decreases with SDR, confirming the results of research
and clinical practice established already over the years by
facilities performing this procedure using the tcMRgFUS system
integrated with a 3-T MRI unit. Therefore, if a patient has a
high SDR value, only low-energy delivery is usually required
to achieve a given temperature, relative to patients with low
SDR values. In Figure 1, the solid lines represent the best fit
curves with power-law function (more information, including
the best fit parameters, is reported in Supplementary Material),
and the dashed lines represent the spline curves that connect the
experimental data. The spline curves are shown to indicate the
point fluctuations observed on these average values.
Moreover, for each patient, the trend of temperature rise with
Em was analyzed. Figure 2 shows this trend for three patients
with different SDR values (0.37, 0.51, and 0.71). It was found
that a higher energy is required in case of patients with low
SDR values to achieve the desired temperature rise because the
skull hampers the HIFU energy transmission by reflecting and
attenuating energy at interfaces differently compared with the
case of patients with high SDR values. Thus, the amount of
energy required to reach a temperature of 50◦C at the target
in the case patients with an SDR of 0.37 and 0.51 was more
than five and two times, respectively, higher than that required
for a patient with an SDR = 0.71. In the case of a patient
with SDR = 0.37, as shown in Figure 2, even if five sonication
processes were performed with increasing energies (Em range 34–
36 kJ), realizing a temperature rise beyond 50◦C was impossible
(temperature at the target previously achieved a more bearable 27
kJ sonication, confirming that the temperature rise is not always
proportional to the increase in sonication power). Furthermore,
the steeper the increase in temperature (i.e., steep slope), the
smaller the total amount of energy delivered at each treatment
stage. Thus, the slope describes the ease with which temperature
can be increased by HIFU exposure in relation to SDR.
Therefore, the slope of the best fit curve was calculated for
each patient and plotted as a function of SDR. The results of
this analysis are illustrated in Figure 3, which clearly indicate
that a correlation exists between the slope of the temperature
vs. energy plot and the SDR (R2 = 0.765; p < 0.001). Therefore,
when treating a patient with a low SDR value, the physician could
face difficulties in locally increasing the temperature that could
lead to suboptimal lesioning and/or longer treatment duration
(the higher the energy released, the longer the system cooling
time). On the contrary, in patients with high SDR values, the
HIFU beam transmission across the skull is less hampered, and
attaining the ablation temperature is thus generally not difficult
even with a low energy delivery.
Figure 4 shows the peak temperature achieved as a function
of SDR. The correlation is significantly positive (R2 = 0.398; p
< 0.005) and further indicates that increasing the temperature
in patients with high SDR values is more feasible. However,
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TABLE 2 | Summary of sonication parameters for each treatment stage for all considered patients.
Treatment
stage
Temperature
(◦C)
Power
(W)
Measured
power
(W)
Actual
power %
Sn
(s)
Energy
(J)
Measured
energy
(J)
Actual
energy %
Tmax
(◦C)
SD of
Tmax
(◦C)
Alignment (I) T < 45 mean 316.15 302.49 95.68 11.43 3,610.14 2,360.17 65.38* 42.89 1.90
Verify (II) 45 ≤ T < 50 mean 413.70 399.22 96.50 13.55 5,238.45 4,899.29 93.53 47.58 1.41
Treat low (III) 50 ≤ T < 55 mean 642.87 614.59 95.60 17.36 10,034.22 9,326.26 92.94 52.41 1.45
Treat high (IV) T ≥ 55 mean 800.14 761.54 95.18 16.84 11,560.96 10,799.17 93.41 57.98 2.55
max 1,300.00 1,218.70 95.68 80.00 39,000.00 36,323.20 93.14 67.93 n.a.
*If releasing a high percentage of planned energy during alignment sonication processes was not possible, the acoustic threshold was increased from the ExAblate workstation (identified
by the vendor as “tissue type level 1” option). Thus, in our analysis, the mean actual energy percentage was lower than that for other treatment stages, even by neglecting inconsistent
sonication processes.
FIGURE 1 | Energy released on the target for various skull density ratio (SDR)
values in the four treatment stages (and related temperature ranges). Dashed
lines represent spline curves that connect the experimental data, and
continuous lines represent the best fit curves (more information is provided in
Table S2). For low SDR range (0.35–0.4), the measured energy values for the
treatment stage III are higher than those for treatment stage IV because we
were unable to achieve an increase in temperature of above 55◦C in six
patients, even by increasing the planned energy.
the correlation coefficient in this case is smaller than that in
Figure 3. It must be noted that, in six patients with SDR < 0.40,
the maximum temperature never exceeded 55◦C (see data in
the bottom left of Figure 4), which agrees with the temperature
limit for lesion consolidation. Last, Figure 4 shows that high
temperature rises (>60◦C) were achieved even in patients with
medium-low SDR values (0.4–0.5), confirming that for SDR
values above 0.4, no correlation between the SDR score and the
maximum temperature achieved is observed.
To obtain further insights about the relationship between
patient- and treatment-related parameters, a Pearson correlation
matrix was calculated (Figure 5). From this analysis, as
mentioned already, a positive significant correlation between
SDR and slope of the temperature and energy plots, and between
SDR and Tmax, is evident. However, these three quantities do not
significantly correlate with Tx nor with SA and are negatively
FIGURE 2 | Maximum peak temperature (Tmax) as a function of measured
energy (Em) for three patients with different skull density ratio (SDR) values
(blue 0.37; red 0.51; green 0.71). Each marker represents a different sonication
process. Dashed line represents the best fit linear curve for each treatment.
correlated with the expected FP at the target, thereby confirming
that high SDR values allow for the desired temperature with a
low total HIFU beam energy delivery to the target. In addition, a
positive correlation between SAs and SAt was found. Finally, the
correlation matrix indicated that SAt is correlated with Txt.
The analysis of intersonication time (St), which is highly
dependent on the planned energy (because the cooling time of
the transducer is automatically calculated in relation to this),
is discussed in Figure S9. Excluding the inconsistent sonication
processes, a total of 1,068 sonication processes were considered.
The elapsed temporal periods between the sonication processes
were as follows: less than 300 s for 477 times (46.9% of total),
<500 s for 746 times (73.4% of total), more than 500 s and
<1,000 s for 213 times (21.1% of total), more than 1,000 s and
<2,000 s for 54 times (5.3% of total), and more than 2,000 s for
three times (0.3% of total).
The analysis of the MR thermometry scanning plane
(see Supplementary Material) per treatment session has been
provided because (in our site) the treating physician found
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FIGURE 3 | Slope of the temperature vs. energy plot as a function of skull
density ratio (SDR) for all of the patients considered. In addition, the best fit
linear curve is shown (blue line). Each marker (red circles) represents a patient.
FIGURE 4 | Maximum peak temperature (Tmax) as a function of skull density
ratio (SDR) for all enrolled patients. In addition, the best fit linear curve is
shown.
monitoring the procedure using the axial and the coronal
planes—that were, respectively, used for an average of 10.4 (SD±
3.8) and 7.7 (SD± 3.0) times, whereas the sagittal plane was used
only 2.5 (SD± 3.0) times per treatment—more reliable. This can
be attributed to the average low SNR of the scans obtained in the
sagittal plane with the MRI setup used in our facility [15].
DISCUSSION
Themain objective of this study was to retrospectively investigate
the relationship between the patient- and the treatment-related
parameters in a group of patients with ET and PD, who
underwent the unilateral thalamotomy procedure of the Vim
nucleus for tremor control by a tcMRgFUS system integrated
with a 1.5-T MRI unit. The relationship between treatment
FIGURE 5 | Correlation matrix of patient- and treatment-related data
calculated for all patients included in this study.
parameters, consolidated thalamic lesion, and the clinical
outcome continue to be areas of investigations [25]. Moreover,
to the best of our knowledge, the relationship between patient-
and treatment-related technical parameters has been investigated
only by Chang et al. on 25 patients [17], of which 15 patients with
ET, one with idiopathic PD, and nine with obsessive-compulsive
disorder (OCD) were treated with a tcMRgFUS system integrated
with a 3-TMRI unit. More recently, the significance of skull bone
characteristics in selecting candidates for the FUS procedure was
investigated in two groups of patients from a single center (98
patients underwent FUS thalamotomy for ET or PD using a 3-T
tcMRgFUS installation and 163 random patients who performed
a head CT scan for various clinical indications) [19]. This study
concluded that, although low SDR values correlate with high-
energy requirement during the FUS procedure, the SDR neither
influences the clinical outcome (1 year follow-up) nor provides
a good index for prediction. Furthermore, the authors reported
that general population SDR sampling does not exhibit any
relationship with both sex and age of patients.
In another recent study [18], the influence of skull bone
characteristics on the efficacy and safety of procedures performed
with a 3-T integrated tcMRgFUS system was investigated using
the data of 189 patients with ET collected from five clinical trials
conducted in six countries. In addition, this study analyzed a
subset of patients with low SDR values and concluded that even
if the percentage improvement in tremor rating scale during a
1 year follow-up is not significantly different across the various
SDR categories, the probability of reaching a target temperature
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of 54◦C in patients with SDR< 0.45 is significantly less compared
with those with SDR ≥ 0.45.
A study by Jung et al. [20] on five non-embalmed cadaver
skulls and 46 patients who underwent tcMRgFUS ablations
under 3-T MRI guidance highlighted the SDR, skull volume, and
incidence angle of acoustic rays against the skull surface as the
most significant factors for a successful energy transmission in a
tcMRgFUS procedure.
The results of our study further corroborate the
abovementioned results and demonstrate the SDR as the
most significant patient-related parameter of all parameters
considered in our analysis and can thus influence a tcMRgFUS
thalamotomy procedure when a 1.5-T MRI scanner is used. Our
study indicates that both the maximum peak temperature in
the focal area and the slope of the temperature and energy plots
are positively correlated with the SDR. Furthermore, in patients
with high SDR values, only a significantly less energy was found
to be necessary to attain the temperature for permanent brain
lesioning (>50◦C) or further consolidate a lesion (>55◦C).
On the contrary, in patients with low SDR values (<0.40),
realizing a temperature rise beyond 50◦C was either difficult
or impossible. Thus, for patients with SDR < 0.4, treatment
could be more difficult even if a significant cumulative thermal
dose can be achieved through multiple sonication processes
with lower focal temperatures. As reported recently by a study
[26], the sonication processes can be repeated to increase the
accumulated thermal dose at the target for the cases where
attaining a temperature beyond 54◦C is impossible (because of
patients with unfavorable SDR values or because of reported
pain during sonication). A similar approach, but with a totally
different objective, has been reported by Gallay et al. [27, 28]
for pallidothalamic tractotomy that was successfully achieved in
105 patients by dividing the target region into several subunits
with multiple sonication processes with the shortest possible
times. This approach could additionally result in increased
tolerability of the procedure because high-energy sonication is
typically not easily tolerable. However, our analyses confirm that
a directly proportional relationship between SDR and energy
delivery at the target is not always present. We studied several
cases in which a Tmax exceeding 55
◦C was easily achieved even
in patients with medium-low SDR values (0.4–0.5). Therefore,
further analysis on the relationship between SDR and energy
delivery (Figure 2) on a larger multi-centric data could not only
be useful for prospective treatment energy titration optimization
but also successfully provide a patient tolerability index and
a feasibility score of the procedure. All these results confirm
the experimental nature of the FUS procedures performed in
the past, and call for further development and optimization in
the future.
Even if we never had cases with low SA and Tx elements values
(seeMaterials andMethods), our experience indicates neither the
number of transducer elements nor the SA as the discriminating
factors for an FUS procedure (see Table 1 for SAs, SAt, Txs, and
Txt values).
However, our study has several limitations. First, we included
all of the patients successfully treated at our university hospital
without considering the learning curve of both the treating
physician and the tcMRgFUS team members (monitoring
physician, nurses, radiology technicians, and anesthesiologists).
Moreover, this procedure was initially highly experimental,
resulting in us facing some challenges and technical snags and/or
device malfunctions (see Table S1). The initial FUS thalamotomy
procedures were usually successfully performed with more
than a total of 20 sonication processes, whereas recently, the
number was significantly small, occasionally even<10 sonication
processes. In addition, a discussion on the duration of the
treatment reported in our results is indispensable (see Figure S9).
For a good estimation of the total treatment, considering an
additional 1-h slot is advantageous for patient preparation
(elastic membrane positioning, helmet filling, MRI planning
scans, procedure planning, and transducer-to-target alignment),
intraoperative MRI anatomical scans, and patient discharging
times (water drainage from the helmet). However, this procedure
time does not include stereotactic frame positioning and removal,
which vary greatly based on the tolerability threshold of
the patients. Furthermore, starting from September 2017, we
upgraded the ExAblate workstation from version 6 to version 7,
which introduced the possibility of dynamically modulating each
sonication according to the planned energy, transducer power,
and sonication duration. Therefore, team expertise and software
updates over time could have influenced the execution of the
procedures and the process of choosing the most appropriate
parameters for each sonication according to the patient-related
parameters. Another limitation is that our study included
patients with different diseases (ET and PD), although we treated
the same target (Vim) in both groups. Nevertheless, a study
[17] has reported no statistically significant differences between
different diseases (ET, PD, and OCD) and related ablation targets
(Vim for ET and PD patients and anterior limb of the internal
capsule for OCD patients).
Despite these limitations, this is the first study to investigate
the relationship between patient- and treatment-related
parameters using a tcMRgFUS system integrated with a 1.5-T
MRI unit on a reasonable number of patients from a single
center. Furthermore, our study has some novelties: the type
of analysis we performed in this study by plotting Em against
SDR, and by plotting the slope of temperature divided by energy
delivery against SDR, has not been reported previously in the
literature. Although it would be preferable to confirm these
results with a multicenter study to compare FUS procedures
parameters, thermal monitoring, targeting accuracy, and clinical
outcomes from both 1.5-T and 3-T sites, our results appear to
be insufficiently highlighting significant differences with respect
to the results reported by Chang et al. [17] when an integrated
3-T FUS system is used. Thus, considering the positive effects of
using an FUS system integrated with a 1.5-T MRI unit [15], this
could facilitate the widespread employment of these devices in
the future. We expect the use of dedicated coils with tcMRgFUS
systems integrated with 3-T MRI units to bridge this gap in
the future. Accordingly, evaluating this aspect will definitely
be interesting, specifically for other currently investigated FUS
applications in the field of neuroscience, such as brain tumor
ablation [12, 29, 30], blood-brain barrier opening [13, 14], and
other non-thermal FUS effects [31], in which a much wider
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region could be considered for treatment and the ability to attain
predefined temperature levels may vary based on the location
of the target and the effect to achieve. Lastly, there are currently
under investigation MRI-based methods to replicate CT-based
measurements of skull properties associated with the success of
tcMRgFUS procedures that may deserve attention in the next
future [32].
CONCLUSIONS
In the past few years, transcranial MRgFUS has gained great
attention in the field of therapeutic brain lesioning, specifically in
stereotactic image-guided procedures for neurological disorders.
Various studies conducted on patients with movement disorders
have reported interesting clinical results that indicate minimal
invasiveness and a very low rate of tcMRgFUS procedure-
associated risks and adverse events. This retrospective study was
conducted to investigate about treatment- and patient-related
parameters obtained from FUS procedures performed using a
1.5-T integrated tcMRgFUS system.
The results of this study contribute to extend the knowledge
on this topic and confirm the limits and difficulties that may
affect an FUS procedure. Our results are in accordance with
the data available in the English literature from FUS procedures
performed using 3-T integrated tcMRgFUS systems. Thus, this
study is beneficial to those operating a tcMRgFUS system,
irrespective of the magnetic field strength. Moreover, we expect
that the possibility of prospectively setting sonication energy
according to the presented curves of energy delivery as a function
of SDR for each treatment stage, and importantly updating the
reference database with data from numerous cases collected
from various treatment facilities across the globe, could lead to
further understanding and greater awareness of this emerging
technology. The experience we gained in this research indicates
that the SDR value still remains one of the most significant
technical parameters to be considered for a successful FUS
procedure even if is not always correlated to the maximum
temperature achievable.
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